Lanean...
Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management
Blockade of the renin–angiotensin–aldosterone system (RAAS) with ACE inhibitors has been a cornerstone of heart failure therapy for over 15 years. More recently, further blockade of RAAS with aldosterone antagonists and angiotensin receptor blockers (ARBs) has been studied. While these therapies hav...
Gorde:
| Argitaratua izan da: | Heart Fail Rev |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013832/ https://ncbi.nlm.nih.gov/pubmed/18351457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10741-008-9092-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|